Metraipolis › archive › dc_aca7ca1a89ce

TB vaccine development: monitoring international patent filings to anticipate access challenges — Europe PMC PMID:41626371

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41626371
DOI
10.3389/fpubh.2025.1726153
License (as archived)
solo-consultazione
Archived
2026-11-06T18:14:04.685Z
SHA-256 of the archived text
4bd583f96d3fdd228a2ee4a08f2e3f6392d3dad6e896e56818eb852d4b780e40
Stable URL of this page
https://metraipolis.com/documento/dc_aca7ca1a89ce

How to cite

TB vaccine development: monitoring international patent filings to anticipate access challenges — Europe PMC PMID:41626371 — Europe PMC (en), https://europepmc.org/article/MED/41626371 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aca7ca1a89ce (Metraipolis archive dc_aca7ca1a89ce, sha256 4bd583f96d3fdd228a2ee4a08f2e3f6392d3dad6e896e56818eb852d4b780e40)
BibTeX
@misc{dcaca7ca1a89ce,
  title = {TB vaccine development: monitoring international patent filings to anticipate access challenges — Europe PMC PMID:41626371},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41626371},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aca7ca1a89ce; sha256 4bd583f96d3fdd228a2ee4a08f2e3f6392d3dad6e896e56818eb852d4b780e40},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41626371. Agents can read the archived copy with the MCP tool read_document.